Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Mesoblast FY EPS $(0.09) Misses $(0.05) Estimate, Sales $17.20M Up From $5.90M YoY

Author: Benzinga Newsdesk | August 29, 2025 03:02am
Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) by 70 percent. This is a 99.05 percent increase over losses of $(8.91) per share from the same period last year. The company reported $17.20 million in sales this quarter. This is a 191.39 percent increase over sales of $5.90 million the same period last year.

Posted In: MESO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist